Nonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer

J Clin Oncol. 2023 Feb 10;41(5):964-969. doi: 10.1200/JCO.22.01609. Epub 2022 Oct 28.
No abstract available

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Breast Neoplasms* / genetics
  • Female
  • Heterozygote
  • Humans
  • Mutation
  • Risk Reduction Behavior

Substances

  • BRCA1 Protein
  • BRCA2 Protein